Category: COVID-19

‘American Diagnosis’: ‘We Need to Be at the Table’: Native-Led Medical Research Aims to Rebuild Trust

Exploitative practices in medical research have contributed to the underrepresentation of Native people in clinical trials. Episode 10 explores the efforts of Indigenous scientists to rebuild this broken trust through tribally controlled research.

Cognitive Rehab May Help Older Adults Clear Covid-Related Brain Fog

People whose brains have been injured by concussions, traumatic accidents, strokes, or neurodegenerative conditions such as Parkinson’s disease can benefit from targeted therapy. Experts also employ therapies for long-covid patients with memory and language problems.

KHN’s ‘What the Health?’: Kansas Makes a Statement

In the first official test vote since the Supreme Court overturned Roe v. Wade, voters in Kansas’ primary said in no uncertain terms they want to keep a right to abortion in their state constitution. Meanwhile, the Senate is still working to reach a vote before summer recess on its health care-climate-tax measure, but progress is slow. Tami Luhby of CNN, Sandhya Raman of CQ Roll Call, and Rachel Cohrs of Stat join KHN’s Julie Rovner to discuss these issues and more. Also this week, Rovner interviews KHN’s Bram Sable-Smith, who wrote the latest KHN-NPR “Bill of the Month” installment about a very expensive ambulance trip.

The Time Has Come for DIY Mandates on Covid

Yes, lots of us suffer from pandemic fatigue and have been getting sloppy about precautions in recent months. But with covid an ongoing menace — and governments reluctant to return to sweeping mandates — it’s time for all of us to step up our game.

KHN’s ‘What the Health?’: Manchin Makes a Deal

In a rare surprise for official Washington, Senate Majority Leader Chuck Schumer and Sen. Joe Manchin (D-W.Va.) announced a deal to expand the planned health bill in the Senate to include provisions raising taxes and addressing climate change. The measure would include a third year of expanded subsidies for the Affordable Care Act, but not health care coverage for people left out of Medicaid in states that failed to expand the program. Meanwhile, the ACA goes back to court, and the Biden administration restores anti-discrimination protections for LGBTQ+ people that were rolled back by the Trump administration. Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico, Sarah Karlin-Smith of the Pink Sheet, and Alice Miranda Ollstein of Politico join KHN’s Julie Rovner to discuss these issues and more. Also this week, Rovner interviews Dr. Céline Gounder of KHN about the latest on the monkeypox outbreak.

Everything You Need to Know About Paxlovid — Especially, Should You Take It?

Paxlovid has eclipsed other available therapies for preventing life-threatening covid symptoms in high-risk patients. But even as doctors praise its effectiveness, many say they have unanswered questions about prescribing the drug and want more and better data about it.

KHN’s ‘What the Health?’: Drug Price Bill Is a Go in the Senate

Two things happened in Washington this week that were inevitable: President Joe Biden tested positive for covid-19, and the Senate agreed to move forward on a budget bill that includes only a sliver of what Biden hoped it would. Still, the bill to allow Medicare to negotiate some drug prices, cap out-of-pocket drug costs for seniors, and extend temporary subsidies for Affordable Care Act insurance premiums would represent a major step if Democrats can get it across the finish line. Meanwhile, abortion battles continue to escalate around the country, with Texas leading the way in restrictions. Shefali Luthra of The 19th, Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico, and Rachel Cohrs of Stat join KHN’s Julie Rovner to discuss these issues and more. Also this week, Rovner interviews Dr. Jack Resneck Jr., the new president of the American Medical Association.

Boost Now or Wait? Many Wonder How Best to Ride Out Covid’s Next Wave

As the country faces a rise in new infections driven by the omicron BA.5 subvariant of the coronavirus, about 70% of people 50 and older who got a first covid-19 booster shot haven’t received the recommended second one, according to the Centers for Disease Control and Prevention. Many undervaccinated Americans have lost interest, and others aren’t sure whether to get boosted again now or wait for vaccines reformulated to target newer strains of the virus.

‘An Arm and a Leg’: One ER Doctor Grapples With the Inequities of American Health Care

This episode is an interview with Dr. Thomas Fisher, author of “The Emergency: A Year of Healing and Heartbreak in a Chicago ER.”

Feds Want a Policy That Advocates Say Would Let Hospitals Off the Hook for Covid-Era Lapses

The pandemic disrupted all sense of normalcy for U.S. hospitals, so federal officials are proposing to pause financial penalties against the facilities and to block public access to key hospital safety data — such as the frequency of falls and sepsis — because of concerns that the data isn’t accurate enough. But consumer advocates are furious about the proposal.